GlassScriptPhysician profile
Brad Stork
NPI 1285675728
$488.08
in general payments reported to CMS, 2019-2025
13 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.16 · 2022: $51.13 · 2023: $68.55 · 2024: $129 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $74.69 | 2025 | |
| Smith+Nephew, INC. | $71.75 | 2024-2025 | Grafix Pl, Pico 7, Stravix |
| Pfizer INC. | $51.65 | 2023-2024 | |
| Integra Lifesciences Corporation | $46.09 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $43.74 | 2021-2022 | |
| Amgen INC. | $32.58 | 2024 | Evenity, Prolia |
| Becton, Dickinson and Company | $31.66 | 2024 | |
| Ethicon US, LLC | $30.99 | 2025 | Stratafix |
| Kowa Pharmaceuticals America, INC. | $29.13 | 2023 | Seglentis |
| Innovation Technologies INC | $23.55 | 2022 | |
| Kerecis Limited | $21.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Avanos Medical | $15.42 | 2023 | On-Q* Pump and Accessories |
| Kyowa Kirin, INC. | $14.89 | 2024 | Crysvita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Stork listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.